Trial Profile
Efficacy and tolerability of fluvastatin in adults with dislipidemia with history of muscle problems due to other previous statin intake
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2019
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary) ; Ezetimibe
- Indications Dyslipidaemias; Lipid metabolism disorders
- Focus Biomarker; Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.